作者
Antti Kiviaho,Sini K. Eerola,Heini Kallio,Maria Andersen,Miina Hoikka,Aliisa M. Tiihonen,I Salonen,Xander Spotbeen,Alexander Giesen,Chris Parker,Sinja Taavitsainen,Olli Hantula,Mikael Marttinen,Ismaïl Hermelo,Mazlina Ismail,Elise Midtbust,Maximilian Wess,Wout Devlies,Abhibhav Sharma,Sebastian Krossa,Tomi Häkkinen,Ebrahim Afyounian,Katy Vandereyken,Sam Kint,Juha Kesseli,Teemu Tolonen,Teuvo L.J. Tammela,Trond Viset,Øystein Størkersen,Guro F. Giskeødegård,Morten Rye,Teemu J. Murtola,Andrew Erickson,Leena Latonen,G. Steven Bova,Ian G. Mills,Steven Joniau,Johannes V. Swinnen,Thierry Voet,Tuomas Mirtti,Gerhardt Attard,Frank Claessens,Tapio Visakorpi,Kirsi J. Rautajoki,May‐Britt Tessem,Alfonso Urbanucci,Matti Nykter
摘要
Abstract Prostate cancer treatment resistance is a significant challenge facing the field. Genomic and transcriptomic profiling have partially elucidated the mechanisms through which cancer cells escape treatment, but their relation toward the tumor microenvironment (TME) remains elusive. Here we present a comprehensive transcriptomic landscape of the prostate TME at multiple points in the standard treatment timeline employing single-cell RNA-sequencing and spatial transcriptomics data from 120 patients. We identify club-like cells as a key epithelial cell subtype that acts as an interface between the prostate and the immune system. Tissue areas enriched with club-like cells have depleted androgen signaling and upregulated expression of luminal progenitor cell markers. Club-like cells display a senescence-associated secretory phenotype and their presence is linked to increased polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) activity. Our results indicate that club-like cells are associated with myeloid inflammation previously linked to androgen deprivation therapy resistance, providing a rationale for their therapeutic targeting.